LaJolla Pharmaceutical Company
United States · Founded 1989
- Employees
- 51–200
- Founded
- 1989
- Business Model
- B2B
- Website
- ljpc.com
Indexed holds 1 funding round for this company. The full record is or through the API.
About
La Jolla Pharmaceutical Company, founded in 1989, is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for patients with life-threatening diseases, including antibody-related and cardiovascular disorders. Its flagship product, GIAPREZA (angiotensin II), is approved to increase blood pressure in adults with septic or other distributive shock. The company was acquired by Innoviva, Inc. in August 2022 for $6.23 per share and now operates as a subsidiary of Innoviva, headquartered in Waltham, Massachusetts.
Summary
LaJolla Pharmaceutical Company is a Biotech company based in United States, founded in 1989.
Company Event History
May 2018
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/lajolla-pharmaceutical-company"><img src="https://indexed.vc/api/badge/company/lajolla-pharmaceutical-company" alt="LaJolla Pharmaceutical Company on Indexed.vc" width="260" height="76" /></a>